217 related articles for article (PubMed ID: 32898858)
1. A prospective, blinded study of a PF4-dependent assay for HIT diagnosis.
Samuelson Bannow B; Warad DM; Jones CG; Pechauer SM; Curtis BR; Bougie DW; Sharma R; Grill DE; Redman MW; Khalighi PR; Leger RR; Pruthi RK; Chen D; Sabath DE; Aster RH; Garcia DA; Padmanabhan A
Blood; 2021 Feb; 137(8):1082-1089. PubMed ID: 32898858
[TBL] [Abstract][Full Text] [Related]
2. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
[TBL] [Abstract][Full Text] [Related]
3. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
Demma LJ; Winkler AM; Levy JH
Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
[TBL] [Abstract][Full Text] [Related]
4. Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.
Wines BD; Tan CW; Duncan E; McRae S; Baker RI; Andrews RK; Esparon S; Gardiner EE; Hogarth PM
J Thromb Haemost; 2018 Dec; 16(12):2520-2525. PubMed ID: 30269432
[TBL] [Abstract][Full Text] [Related]
5. A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia Antibodies.
Jones CG; Pechauer SM; Curtis BR; Bougie DW; Irani MS; Dhakal B; Pierce B; Aster RH; Padmanabhan A
Chest; 2017 Oct; 152(4):e77-e80. PubMed ID: 28991552
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
Nazi I; Arnold DM; Warkentin TE; Smith JW; Staibano P; Kelton JG
J Thromb Haemost; 2015 Oct; 13(10):1900-7. PubMed ID: 26291604
[TBL] [Abstract][Full Text] [Related]
8. Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia.
Raschke RA; Gallo T; Curry SC; Whiting T; Padilla-Jones A; Warkentin TE; Puri A
J Thromb Haemost; 2017 Aug; 15(8):1640-1645. PubMed ID: 28622439
[TBL] [Abstract][Full Text] [Related]
9. P-selectin expression assay in a repeatedly serotonin-release assay-negative patient with heparin-induced thrombocytopenia.
Arora K; Rodgers S; Alkhatib Y; Onwubiko IN; Padmanabhan A; Otrock ZK
Blood Coagul Fibrinolysis; 2021 Oct; 32(7):522-525. PubMed ID: 34261860
[TBL] [Abstract][Full Text] [Related]
10. Improving clinical interpretation of the anti-platelet factor 4/heparin enzyme-linked immunosorbent assay for the diagnosis of heparin-induced thrombocytopenia through the use of receiver operating characteristic analysis, stratum-specific likelihood ratios, and Bayes theorem.
Raschke RA; Curry SC; Warkentin TE; Gerkin RD
Chest; 2013 Oct; 144(4):1269-1275. PubMed ID: 23703622
[TBL] [Abstract][Full Text] [Related]
11. Serotonin-release assay-negative heparin-induced thrombocytopenia.
Warkentin TE; Nazy I; Sheppard JI; Smith JW; Kelton JG; Arnold DM
Am J Hematol; 2020 Jan; 95(1):38-47. PubMed ID: 31621093
[TBL] [Abstract][Full Text] [Related]
12. Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study.
Linkins LA; Bates SM; Lee AY; Heddle NM; Wang G; Warkentin TE
Blood; 2015 Jul; 126(5):597-603. PubMed ID: 25926600
[TBL] [Abstract][Full Text] [Related]
13. Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL
Warkentin TE; Sheppard JI; Linkins LA; Arnold DM; Nazy I
Thromb Res; 2017 May; 153():108-117. PubMed ID: 28391124
[TBL] [Abstract][Full Text] [Related]
14. Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.
Warkentin TE; Arnold DM; Kelton JG; Sheppard JI; Smith JW; Nazy I
Chest; 2018 Jun; 153(6):1396-1404. PubMed ID: 29325985
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
[TBL] [Abstract][Full Text] [Related]
16. New platelet functional method for identification of pathogenic antibodies in HIT patients.
Guarino ML; Massimi I; Mardente S; Lappa A; Donfrancesco S; Visentin GP; Pulcinelli FM
Platelets; 2017 Nov; 28(7):728-730. PubMed ID: 28287032
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia.
Izban KF; Lietz HW; Hoppensteadt DA; Jeske WP; Fareed J; Bakhos M; Walenga JM
Semin Thromb Hemost; 1999; 25 Suppl 1():51-6. PubMed ID: 10357152
[TBL] [Abstract][Full Text] [Related]
18. Prospective observational evaluation of the particle immunofiltration anti-platelet factor 4 rapid assay in MICU patients with thrombocytopenia.
Andrews DM; Cubillos GF; Paulino SK; Seckinger DL; Kett DH
Crit Care; 2013 Jul; 17(4):R143. PubMed ID: 23876263
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopenia.
Rubino JG; Arnold DM; Warkentin TE; Smith JW; Kelton JG; Nazy I
J Thromb Haemost; 2021 Apr; 19(4):1096-1102. PubMed ID: 33387395
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.
Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A
Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]